NCT04378049

Brief Summary

This is a pilot randomized trial to assess the feasibility of a definitive trial to determine the effect of robot-assisted partial knee replacements versus standard total knee replacements.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable knee-osteoarthritis

Timeline
7mo left

Started Nov 2020

Longer than P75 for not_applicable knee-osteoarthritis

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Nov 2020Dec 2026

First Submitted

Initial submission to the registry

May 4, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 7, 2020

Completed
7 months until next milestone

Study Start

First participant enrolled

November 23, 2020

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

May 9, 2025

Status Verified

May 1, 2025

Enrollment Period

6 years

First QC Date

May 4, 2020

Last Update Submit

May 6, 2025

Conditions

Keywords

Total knee arthroplastyUnicompartmental knee arthroplastyRobot-assisted surgeryPilot randomized controlled trialBicompartmental knee arthroplastyMako partial knee

Outcome Measures

Primary Outcomes (3)

  • Feasibility- Recruitment

    The number of patients recruited during a 12 month period

    12 months

  • Feasibility- Participant retention

    Number of patients completing the study

    12 months

  • Feasibility- Treatment compliance

    The number of crossovers during a 12 month period

    12 months

Secondary Outcomes (12)

  • Return to function questionnaire

    12 months post-surgery

  • Oxford knee score

    12 months post-surgery

  • Forgotten joint score

    12 months post-surgery

  • Gait walking mechanics analysis

    12 months post-surgery

  • Quality of life- EQ-5D

    12 months post-surgery

  • +7 more secondary outcomes

Study Arms (2)

Standard total knee arthroplasty

ACTIVE COMPARATOR

Participants who are randomized to the control group will undergo TKA according to local standard of care. The choice of implant and use of bone cement will be recorded but left to the surgeon's discretion according to their standard practice.

Procedure: Total knee arthroplasty

Robot-assisted partial knee arthroplasty

EXPERIMENTAL

Participants with isolated medial or isolated lateral compartment OA who are randomized to the intervention group and have one affected knee compartment will receive a robot-assisted unicompartmental knee arthroplasty (UKA). If the patient has medial or lateral OA plus patellofemoral OA they will receive a bicompartmental knee arthroplasty (BiKA) consisting of a two simultaneous UKAs. The partial knee replacement procedures will be performed using the Mako RIO robotic arm (Stryker) according to the manufacturer's instructions. The choice of implant and use of bone cement will be recorded but will be left to the surgeon's discretion. Surgeons will resurface the patella if the patellar cartilage meets Outerbridge grade 3 or 4 criteria

Procedure: Robot-assisted partial knee arthroplasty

Interventions

Surgeon will perform a total knee arthroplasty procedure according to local standard of care

Also known as: Total knee replacement
Standard total knee arthroplasty

Surgeon will perform a robot-assisted unicompartmental or bicompartmental knee arthroplasty procedure

Also known as: MakoPlasty
Robot-assisted partial knee arthroplasty

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult (18+)
  • Unicompartmental knee OA with or without concomitant patellofemoral OA, requiring surgical treatment
  • Two study surgeons independently agree that the patient is eligible for either treatment group

You may not qualify if:

  • Inability to provide informed consent (e.g. cognitive disability, language barrier)
  • Revision knee surgery
  • Simultaneous bilateral knee surgery
  • Previous major knee surgery or trauma
  • The robot or required components are unavailable (e.g. technical difficulties, robot-specific disposables out of stock)
  • A CT scan cannot be obtained prior to surgery
  • Patient does not wish to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Joseph's Healthcare Hamilton

Hamilton, Ontario, L8N 4A6, Canada

Location

Related Publications (1)

  • Madden K, Flood B, Malek M, Milantoni V, Astephen Wilson JL, Tarride JE, Khanna V, Adili A; RoboKnees Investigators. Robot-assisted partial knee replacement versus standard total knee replacement (RoboKnees): a protocol for a pilot randomized controlled trial. Pilot Feasibility Stud. 2024 Feb 21;10(1):39. doi: 10.1186/s40814-024-01463-x.

MeSH Terms

Conditions

Osteoarthritis, Knee

Interventions

Arthroplasty, Replacement, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Study Officials

  • Anthony Adili, MD, P.Eng, FRCSC

    McMaster University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Surgeons cannot be blinded to treatment group. It would not be feasible to blind the health care team and patients because the incisions and imaging are visually distinguishable. We will attempt to minimize bias in subjective measures by presenting patients with balanced information on each treatment group prior to the trial. All participants will receive a computed tomography (CT) scan prior to surgery to maintain blinding and to give surgeons additional information about 3 dimensional modelling for implant placement. Data analysts will be blinded to treatment allocation. An independent outcomes assessor will independently review radiographic alignment for each patient and review relatedness of adverse events and re-operations. The independent assessor cannot be blinded because imaging is visually distinguishable.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 4, 2020

First Posted

May 7, 2020

Study Start

November 23, 2020

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

May 9, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

We will share data upon reasonable request for non-commercial purposes. This may require an institutional data-sharing agreement.

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
Upon study completion.

Locations